3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2/3
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Conditions
Esophageal Neoplasms
7
Malnutrition
4
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Head and Neck Neoplasms
2
Postoperative Complications
1
Pancreatitis, Chronic
1
Nutritional Support
1
Muscular Atrophy
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Infections
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Duodenal Neoplasms
1
Digestive System Neoplasms
1
Cholangiocarcinoma
1
Child Nutrition Disorders
1
Cerebral Palsy
1
Carcinoma, Non-Small-Cell Lung
1
Cachexia
1
Bile Duct Neoplasms
1
Interventions
pembrolizumab
180
Gemcitabine
168
Paclitaxel
150
Carboplatin
134
Bevacizumab
126
Cisplatin
113
Docetaxel
112
Cyclophosphamide
109
Exercise
97
Nivolumab
93
Fluorouracil
88
Capecitabine
85
Dexamethasone
81
Irinotecan
74
Radiotherapy
68
Oxaliplatin
68
Pemetrexed
66
Standard of Care
64
Leucovorin
63
Cetuximab
59
Sorafenib
53
Erlotinib Hydrochloride
53
Drug Therapy
53
Blood Specimen Collection
51
Doxorubicin
50
atezolizumab
48
trametinib
47
Ipilimumab
47
Albumin-Bound Paclitaxel
44
130-nm albumin-bound paclitaxel
42
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasms
×
Enteral Nutrition
×
Clear all
NCT07341464
2026-01-14
Blends
Société des Produits Nestlé (SPN)
Phase NA
Recruiting
50 enrolled
NCT06175273
2025-09-18
POINT
University of Kentucky
Phase 2/3
Completed
19 enrolled